Compare CADL & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | YELP |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | N/A | 5168 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2021 | 2011 |
| Metric | CADL | YELP |
|---|---|---|
| Price | $11.74 | $18.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | $19.00 | ★ $29.17 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | 19.15 |
| EPS | N/A | ★ 0.86 |
| Revenue | $125,000.00 | ★ $1,464,955,000.00 |
| Revenue This Year | N/A | $2.19 |
| Revenue Next Year | N/A | $2.34 |
| P/E Ratio | ★ N/A | $22.57 |
| Revenue Growth | N/A | ★ 3.75 |
| 52 Week Low | $4.35 | $19.37 |
| 52 Week High | $14.00 | $34.49 |
| Indicator | CADL | YELP |
|---|---|---|
| Relative Strength Index (RSI) | 48.82 | 28.91 |
| Support Level | $9.40 | N/A |
| Resistance Level | $14.00 | $24.91 |
| Average True Range (ATR) | 0.71 | 0.74 |
| MACD | -0.18 | -0.15 |
| Stochastic Oscillator | 46.56 | 0.82 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.